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High-mobility group protein 1 (HMGB1) is an essential and ubiquitous DNA
architectural factor that influences a myriad of cellular processes. HMGB1
contains two DNA-binding domains, box A and box B, which have little
sequence specificity but have remarkable abilities to underwind and bend DNA.
Although HMGB1 box A is thought to be responsible for the majority of
HMGB1–DNA interactions with pre-bent or kinked DNA, little is known about
how it recognizes unmodified DNA. Here, the crystal structure of HMGB1 box
A bound to an AT-rich DNA fragment is reported at a resolution of 2 A˚. Two
box A domains of HMGB1 collaborate in an unusual configuration in which the
Phe37 residues of both domains stack together and intercalate the same CG
base pair, generating highly kinked DNA. This represents a novel mode of DNA
recognition for HMGB proteins and reveals a mechanism by which structure-
specific HMG boxes kink linear DNA.
1. Introduction
High-mobility group protein 1 (HMGB1) is a DNA archi-
tectural factor that affects numerous cellular processes by
modulating chromatin structure (Thomas & Travers, 2001).
It participates in the regulation of transcription, chromatin
remodeling, recombination and DNA repair, and is requisite
for transposition in gene therapy (Ivics et al., 2004; Malarkey
& Churchill, 2012; Sˇtros, 2010). In an extracellular role,
HMGB1 is a danger signal in inflammatory conditions,
including autoimmunity and cancer (Klune et al., 2008; Kang et
al., 2014; Yang et al., 2013).
HMGB1 is the archetypal member of the HMGB proteins,
a large family of proteins that includes many transcription
factors and chromosomal proteins such as mammalian
HMGB1–4, TFAM (mitochondrial transcription factor A),
NHP6A/B (Saccharomyces cerevisiae) and HMGD (Droso-
phila melanogaster), as well as sequence-specific transcription
factors such as TCF/LEF-1 and sex-determining factor SRY
and SOX proteins among others (Malarkey & Churchill, 2012;
Sˇtros, 2010). The HMG box is the defining and characteristic
domain of the HMGB family (Landsman & Bustin, 1993). This
domain comprises three -helices with an L-shaped structure,
in which helix I and II form a short arm and helix III together
with an N-terminal stretch of amino acids forms a long arm
(Weir et al., 1993; Read et al., 1993; Jones et al., 1994).
Although many HMGB family members have only one HMG
box, HMGB1 has two HMG boxes (A and B), the solution
structures of which have been determined by NMR (Hardman
et al., 1995; Wang et al., 2013; Weir et al., 1993), and the HMG
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boxes are followed by an intrinsically disordered C-terminal
tail.
A hallmark of HMGB proteins is their ability to recognize
the minor groove of pre-bent, distorted or linear DNA,
bending linear DNA between 70 and 180 towards the major
groove (Dragan et al., 2003, 2004; Werner et al., 1995). The
HMGB1 domains are unequal in these properties: box A
recognizes both pre-bent (Teo, Grasser & Thomas, 1995) and
linear DNA more tightly than box B (Mu¨ller et al., 2001), but
box B binds to mini-circles (Webb et al., 2001) and bends linear
DNA to a greater extent than box A (Paull et al., 1993; Teo,
Grasser & Thomas, 1995). This dramatic distortion of DNA is
dependent on both shape complementarity and DNA inter-
calation of two apolar residues (Churchill et al., 2010; Klass et
al., 2003; Murphy & Churchill, 2000; Roemer et al., 2008). The
primary intercalation residue is in helix I (1 in Fig. 1) and the
second intercalation wedge (2 in Fig. 1) is at the start of helix
II. HMGB1 box A is an exception because Ala16 at the 1 site
cannot intercalate DNA but Phe37 at the 2 site can, and this is
thought to be responsible for the superior ability of box A to
recognize pre-bent DNA (reviewed by Sˇtros, 2010). Indeed,
the crystal structure of box A bound to cisplatin intrastrand
GG cross-linked DNA showed Phe37 lodged into the
cisplatin-induced kink, although the DNA itself was relatively
undistorted compared with the free cisplatin-modified DNA
(Ohndorf et al., 1999). However, how box A recognizes
natural, unmodified DNA remains unknown.
In order to understand how a structure-specific HMG box
can recognize linear unmodified DNA, we determined the
crystal structure of HMGB1 box A in complex with an AT-rich
DNA fragment. Rigorous structural analysis of this structure
revealed remarkable differences in the mode of DNA binding
in comparison to non-sequence-specific HMG boxes bound to
linear DNA (Murphy et al., 1999; Murphy & Churchill, 2000;
Allain et al., 1999; Churchill et al., 2010) and interesting
similarities to the mode of binding observed for the pre-bent
DNA (Ohndorf et al., 1999).
2. Materials and methods
2.1. Expression and purification of the protein and DNA
Plasmid pGEX2T containing GST-tagged rat HMGB1 box
A domain (Lys7–Pro80 in Fig. 1; Roemer et al., 2008) was
expressed in Escherichia coli Rosetta(DE3)pLysS strain. Cells
were grown in the presence of ampicillin and chloramphenicol
at 37C with vigorous shaking until the absorbance at 600 nm
reached 0.8. Expression of the fusion protein was then induced
by the addition of 0.5 mM IPTG. The bacterial cells were
harvested by centrifugation at 5000g for 10 min.
The protein was purified as follows. The resuspended pellet
was sonicated in buffer 1 (20 mM Tris pH 7.9, 0.5M NaCl,
10 mM EDTA, 1 mM DTT, 10% glycerol) with DNaseI and
protease inhibitors (cOmplete protease-cocktail tablets,
Roche). The clarified lysate was incubated with glutathione
Sepharose 4B beads (GE Healthcare) pre-equilibrated with
buffer 1 by rotating for 2 h at 4C. The GST beads were then
washed five times with wash buffer (20 mM Tris pH 7.9, 1M
NaCl, 10 mM EDTA, 1 mM DTT) and three times with
thrombin buffer (20 mM Tris pH 7.9, 100 mM NaCl, 2.5 mM
CaCl2, 1 mM DTT). The protein was cleaved with 200 U ml
1
thrombin by rotating overnight at 4C and the protein was
eluted from the beads with elution buffer (10 mM Tris pH 7.9,
100 mM NaCl, 10 mM EDTA, 1 mM DTT). The protein was
further purified using a HiTrap SP FF cation-exchange column
(GE Healthcare) pre-equilibrated with elution buffer. The
protein was eluted with a linear gradient to a final concen-
tration of 1M NaCl in the same buffer. The most pure
fractions as assessed by SDS–PAGE were pooled and
concentrated for final purification via size-exclusion chroma-
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Figure 1
HMG-box sequence comparison. Sequence alignment of non-sequence-specific HMG-box proteins: HMGB1 (rat; rHMGB1-A, box A; rHMGB1-B, box
B), HMGD (Drosophila), NHP6A (S. cerevisiae), sequence-specific/non-sequence-specific TFAM (human mitochondria; TFAM-HMG1, box A; TFAM-
HMG2, box B) and sequence-specific SRY (human) and LEF1 (mouse). The three -helices of the HMG box are shown above the alignment. Arrows
indicate the 1 and 2 intercalating residues. Conserved residues (Clustal Omega alignment) are highlighted in gray, where an asterisk (*) indicates
complete conservation, a colon (:) indicates conservation between groups with strongly similar properties and a dot (.) indicates conservation between
groups with weakly similar properties.
tography (Superdex 75 16/600, GE Healthcare). Pure frac-
tions, based on analysis by SDS–PAGE, were pooled, dialyzed
(25 mM HEPES pH 7.4 at 4C, 75 mM NaCl, 1 mM DTT) and
concentrated to 54 mg ml1 by ultrafiltration (Vivaspin, GE
Healthcare; Microcon, Millipore). The final protein concen-
tration was calculated from the A280 using an extinction
coefficient of 9770M1 cm1 calculated using Peptide Prop-
erty Calculator v.1.0 (A. Chazan, Northwestern University,
Illinois, USA; http://www.basic.northwestern.edu/biotools/
proteincalc.html). The protein mass was confirmed by matrix-
assisted laser desorption/ionization mass spectrometry
(MALDI-TOF) by comparison of the experimental molecular-
weight value (8924 Da) and the theoretical value (8929 Da).
The d(ATATCGATAT)2 oligonucleotide, synthesized in an
automatic synthesizer by the phosphoramidite method and
purified by gel filtration and reverse-phase HPLC, was
supplied by the Pasteur Institute. The DNA was dissolved in
25 mM sodium cacodylate pH 6.5 buffer. The final concen-
tration was calculated from the A260 using an extinction
coefficient of 106.2 mM1 cm1.
2.2. Electrophoretic mobility shift assays (EMSAs)
DNA-binding assays were performed on nondenaturing 6%
polyacrylamide gels. 1 mM oligonucleotide and increasing
concentrations of box A domain were incubated for 30 min in
0.33 TBE (30 mM Tris–borate, 0.66 mM EDTA) and 3%
glycerol. Electrophoresis was carried out at 125 V for 30 min
at 4C. Gels were stained with SYBR Gold (Life Technolo-
gies) and visualized with UV light using a Gel Doc XR
(Bio-Rad).
2.3. Supercoiling assays
0.3 mg of relaxed pSTATCEN plasmid (4.5 kb) was
prepared by treatment of the supercoiled DNA with topo-
isomerase I at 37C for 1 h. Extra topoisomerase I and
increasing amounts of box A domain or didomain AB were
added to the reactions. The reaction mixtures were incubated
at 37C for 1 h in two different buffers: 100 mM NaCl, 5 mM
MgCl2, 35 mM Tris pH 7.5, 1 mMDTT (high ionic strength) or
10 mM NaCl, 5 mM MgCl2, 35 mM Tris pH 7.5, 1 mM DTT
(low ionic strength). Reactions were stopped by the addition
of 0.5% SDS and 0.25 mg ml1 proteinase K and incubation at
37C for 30 min. Electrophoresis of topoisomer populations
was carried out in 1% agarose gel in 1 TPE (90 mM Tris–
phosphate, 2 mM EDTA) at 90 V for 2 h. The gels were
stained with SYBR Gold (Invitrogen, Life Technologies) and
photographed with UV transillumination.
2.4. Crystallization, data collection and structure
determination
Crystals of HMGB1 box A bound to d(ATATCGATAT)2
were obtained by the hanging-drop vapor-diffusion method.
The protein–DNA complex was obtained by incubation (with
final concentrations of 1.6 mM protein and 0.8 mM DNA) for
approximately 1 h at 4C. A hanging drop consisting of 1.5 ml
complex solution and 1.5 ml buffer from the Natrix screen
(Hampton Research) consisting of 40 mM MgCl2, 50 mM
sodium cacodylate pH 6.0, 5% 2-methyl-2,4-pentanediol
(MPD) was equilibrated against 40% MPD. High-quality
needle-shaped crystals obtained from this drop (10 
150 mm) were flash-cooled and stored in liquid nitrogen. X-ray
data were collected on the BL13-XALOC beamline at the
ALBA synchrotron, Barcelona, Spain ( = 0.97949 A˚) using a
PILATUS 6M detector (Dectris).
The data were processed with HKL-2000 (Otwinowski &
Minor, 1997). The space group of the complex was P212121,
with unit-cell parameters a = 42.79, b = 84.29, c = 94.31 A˚, as
confirmed with POINTLESS (Evans, 2006). Assuming the
presence of two DNA duplexes and two protein molecules in
the asymmetric unit, the Matthews coefficient was estimated
to be 2.82 A˚3 Da1, with a solvent content of 60%
(Kantardjieff & Rupp, 2003; Matthews, 1968).
In a first unsuccessful attempt to solve the structure,
an ideal B-DNA was constructed with TURBO-FRODO
(Roussel et al., 1998). This DNA and the full protein coordi-
nates of HMGB1 box A (Pro8–Tyr77 in Fig. 1; Ohndorf et al.,
1999; PDB entry 1ckt) were used as a search model for
molecular replacement. Finally, the structure was solved by
trimming the DNA model and using Phaser (McCoy et al.,
2005). Two d(ATAT)2 fragments were located and placed at
the appropriate angle as indicated by the orientation of the
stacking reflections. Next, the two HMGB1 box A models
were added, one by one, to the structure using MOLREP
(Vagin & Teplyakov, 2010) and fitted in accordance with the
previously placed DNA fragments. The missing central CG
base pairs of the duplex and the missing protein residues were
added using Coot (Emsley & Cowtan, 2004). Finally, a second
straight DNA duplex was located with MOLREP. Real-space
refinement was performed with Coot. At this point, we were
surprised to find that the asymmetric unit contained two
different DNA duplexes: one bent and complexed with two
proteins and the other free and straight (Supplementary Fig.
S3). We carried out maximum-likelihood refinement using
REFMAC5 (Murshudov et al., 2011). After several cycles,
noncrystallographic symmetry restraints were applied, and
TLS refinement was performed in the last round. The struc-
ture was validated with Coot and MolProbity (Chen et al.,
2010). Electron density for the C-terminal Pro80 in both box
A domains was not observed. The average root-mean-square
deviation (r.m.s.d.) between the C atoms of the two box A
domains was 0.49 A˚, with an r.m.s.d. of 0.94 A˚ for all atoms.
Details of data and refinement statistics are given in Table 1.
DNA parameters were calculated using 3DNA (Lu &
Olson, 2003). The axis of the oligonucleotide was obtained
with Curves+ (Lavery et al., 2009). A schematic diagram of the
protein–nucleic acid interactions was drawn using NUCPLOT
(Luscombe et al., 1997). Figures were prepared with PyMOL
(Schro¨dinger) and Coot (Emsley & Cowtan, 2004). The
r.s.m.d. values and the superimposed models for the different
HMG box A domains were obtained using SUPERPOSE
(Sievers et al., 2011). Amino-acid sequences were aligned
using Clustal Omega (Maiti et al., 2004) with UniProt acces-
sion numbers P63159 (HMGB1), Q05783 (HMGD), P11632
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(NHP6A), Q00059 (TFAM), Q05066 (SRY) and P27782
(mLEF1) (The UniProt Consortium, 2014).
3. Results
3.1. General view of the structure
We have determined the crystal structure of HMGB1 box
A bound to the linear duplex DNA d(ATATCGATAT)2
(Table 1). The interaction between box A and DNA was
verified by electrophoretic mobility shift assays (Supplemen-
tary Fig. S1a). The refined model at a resolution of 2.0 A˚ was
well resolved (Supplementary Fig. S2a), with an asymmetric
unit comprising one unbound straight DNA duplex and one
bent DNA duplex bound by two box A domains (Supple-
mentary Fig. S3a). These duplexes form a pseudo-continuous
helix throughout the crystal (Supplementary Fig. S3b). The
structure also contains a single hexahydrated magnesium ion
and a network of water molecules (Supplementary Fig. S2b).
The two box A domains bind in an approximately
symmetric manner about the dyad axis of the palindromic
DNA decamer, with water-mediated interactions between the
domains (Supplementary Fig. S4). Molecule A contacts one
half of the duplex, from A1/T20 to C5/G16, and molecule B
contacts the other half, from G6/C15 to T10/A11 (Figs. 2a, 2b and
3a). The two domains enclose the DNA (Figs. 2a and 2c),
unwinding and bending it by approximately 85, with inter-
calation of the two Phe37 residues at the central CG base pair
(Figs. 2b and 2d and Supplementary Table S1). This tail-to-tail
mode of binding places both Phe37 side chains in a cleft
created in the DNAminor groove (Figs. 2b and 2d), producing
a prominent kink in the DNA towards the major groove. The
two phenyl rings of Phe37 are parallel to each other at 3.5 A˚, a
distance indicative of -stacking. These features contrast with
the other multi-domain HMG-box–DNA structures: HMGD
domains interact in a head-to-head orientation (Murphy et al.,
1999), SRY.B domains bind in a head-to-head fashion with the
two 2 intercalation sites separated by 16 bp (Stott et al., 2006)
and TFAM HMG domains bind tail to tail but the two 2
intercalation sites are separated by 11 bp (Ngo et al., 2011,
2014; Rubio-Cosials et al., 2011). Thus, this collaborative
binding mode, whereby the 2 intercalation residues of two
HMG box A domains act in the same base step, has not
previously been observed.
3.2. Similarities to other HMG boxes
The interactions of both box A molecules with DNA
(Fig. 3a) share many features with other HMGB–DNA
complexes. The overall orientations with respect to the DNA
of the N-terminal stretch and globular core are conserved
(Figs. 2c and 2d). Hydrogen bonds from Arg23 and Trp48 to
the sugar-phosphate backbone are also well conserved;
specifically, this was observed in DNA complexes with SRY.B
(Stott et al., 2006), DNA–cisplatin–box A (Ohndorf et al.,
1999), HMGD (Murphy et al., 1999), NHP6A (Allain et al.,
1999), SRY (Werner et al., 1995) and LEF1 (Love et al., 1995).
In fact, Trp48 has been found to be important for the super-
coiling activity of HMGB1 box A (Teo, Grasser, Hardman et
al., 1995). Despite this overall conservation of protein–DNA
interactions, the HMG boxes HMGB1 box B, HMGD, TFAM
and NHP6A differ in their DNA-bending properties. They
bend DNA over more than one base-pair step (Fig. 3c) rather
than at just a single base step as observed here for box A,
which gives rise to the DNA kink.
3.3. Unique features of the complex
The interaction of Phe37 with the DNA kink is central to
the unique mode of DNA recognition seen in this HMGB box
A–DNA structure. Phe37 is also important for the recognition
of structured DNA, as He et al. (2000) discovered when the
Phe37Ala mutant no longer bound to pre-bent DNA. In our
structure, Phe37 forms hydrogen bonds to G6 (N2) (Fig. 3b)
and is buttressed by van der Waals contacts between Ser38 and
the deoxyriboses of G6 and A7 adjacent to Phe37. The
hydroxyl H atom of Ser41 forms a hydrogen bond to A7 (N3)
and van der Waals contacts with G6 and A7. However, this
interaction of Phe37 and Ser41 with GA base pairs was also
found in the structure of cisplatin–DNA–box A.
A feature of HMGB1 is its ability to bind to DNA in a non-
sequence-specific fashion. It is thought that the two equivalent
residues in LEF1 (Ser37 and Asn41) and SRY (Ser38 and
Ser41) contribute to their sequence specificity because these
residues form direct hydrogen bonds to the DNA bases
(Werner et al., 1995; Love et al., 1995). Residue 13, which has
also been implicated in the sequence specificity of these
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Table 1
Data and refinement statistics.
Values in parentheses are for the highest resolution shell.
Data collection
Space group P212121
Unit-cell parameters (A˚, ) a = 42.8, b = 84.2, c = 94.2,
 =  =  = 90.0
Resolution (A˚) 42.12–2.00 (2.07–2.00)
Rmerge (%) 11.3 (65.8)
hI/(I)i 16.0 (1.90)
Completeness (%) 98.9 (93.5)
Multiplicity 7.1 (5.1)
Refinement
No. of reflections 22219
Rwork/Rfree (%) 19.9/23.4
Wilson B factor (A˚2) 35.7
No. of atoms
Protein 1254
DNA 808
Mg2+ 1
Water 115
Total 2178
B factors (A˚2)
Protein 44.4
DNA 37.6
Mg2+ 21.1
Average 42.4
R.m.s. deviations
Bond lengths (A˚) 0.016
Bond angles () 1.62
Ramachandran plot statistics (%)
Most favored region 98.54
Allowed region 1.46
Disallowed region 0
PDB code 4qr9
transcription factors, is here a serine that makes a water-
mediated hydrogen bond to A9 (N3) (Fig. 3b). Interestingly,
this interaction is not observed in the cisplatin–DNA–box A
complex. However, equivalent interactions of this serine with
DNA in the HMGD (Murphy et al., 1999) and HMGB1 box B
(Stott et al., 2006) structures have been observed, but they did
not contribute to the sequence specificity of the HMG box
(Klass et al., 2003). Therefore, although in the HMG box A–
DNA structure Ser13 together with Ser41 and Tyr15 partici-
pates in a water network that interconnects the central bases
A3, T4 and C5 (and A13, T14 and C15), this is not expected to
contribute to any sequence selectivity of box A.
3.4. DNA deformation
The distortion of the DNA induced by box A domains is
remarkably similar to that imposed solely by the cisplatin
cross-link. At the kink in the box A–DNA structure, the minor
groove widens, the major groove narrows and the DNA is
underwound (Supplementary Fig. S1b, Table S1 and Movie
S1); in particular, the C5G6/C15G16 base step has a roll angle of
74.85, a twist angle of 4.82 and a rise of 6.64 A˚, compared
with standard values of a roll of 0.60, a twist of 36.00 and a
rise of 3.32 A˚ for B-DNA (Olson et al., 2001). These DNA
deformations are only slightly larger than those seen in the
cisplatin-modified DNA–box A structure (Ohndorf et al.,
1999), where the roll values at the kink are 74.85 and 60.61,
respectively (Figs. 3c and 3d). The r.m.s.d. between the DNA
duplex of this structure and the box A–cisplatin-modified
DNA (Ohndorf et al., 1999) is 3.23 A˚, and is 2.59 A˚ for a
similar, but unbound, cisplatin-modified DNA (Takahara et
al., 1996). Thus, the collaborative binding of both box A
domains distorts DNA similarly to cisplatin alone.
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Figure 2
The two near-symmetric box A domains collaborate to bend DNA. (a) View of both domains enclosing the kinked DNA. The HMGB1 box A domains
are colored purple and cyan, whereas the kinked DNA is colored orange. Phe37 of both domains is indicated. (b) View showing the 2 intercalation site,
with the two phenylalanines at the central CG base pair. (c) Surface representation of the two box A domains. (d) Surface representation of the DNA
showing the pocket enclosing the two Phe37 residues (indicated by arrows).
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Figure 3
The kinked DNA structure. (a) DNA–box A contacts (NUCPLOT). Hydrogen bonds are shown as solid lines and nonbound contacts are shown as
dashed lines. (b) Close-up views of the protein–DNA purine base interactions. Hydrogen bonds from residues Phe37 and Ser41 to base pairs A7 and G6
and a water-mediated hydrogen bond from Ser13 to A9 are shown in the upper and lower diagrams, respectively. (c) Comparison of DNA parameters for
HMG-box intercalation sites. The roll and twist angles for box A in this structure were obtained with 3DNA, and those for PDB entries 1ckt (box A,
cisplatin; Ohndorf et al., 1999), 2gzk (box B; Stott et al., 2006), 1qrv (HMGD; Murphy et al., 1999), 1j5n (NHP6A; Masse et al., 2002) and 3tmm (TFAM;
Ngo et al., 2011) were taken from the Nucleic Acids Data Bank (NDB; see also Supplementary Table S2). (d) Superimposition of box A kinked DNA
(orange) with cisplatin-modified DNA (grey).
3.5. Box A structure and comparisons
The structure of box A adapts to unmodified DNA differ-
ently than to cisplatin-modified DNA. The overall r.m.s.d. for
the box A domains in the two structures is 1.68 A˚ (Fig. 4a and
Supplementary Table S2). The main differences are found
near Phe37, in the loop between helix I and II, and in helix I,
which is straighter when box A is bound to cisplatin-modified
DNA. However, in both box A–DNA structures helix II is
relatively straight, unlike any of the other free HMG box A
structures (Fig. 4). This configuration of helix II might facil-
itate the interaction of Phe37 with the DNA kink site and
shows that box A can adopt different conformations in
different contexts.
The orientation of Phe37 is altered by the oxidation of Cys
residues in HMGB1 (Wang et al., 2013). One consequence of
such oxidation is the shuttling of the oxidized HMGB1 out of
the nucleus to the cytosol and extracellular matrix, where it
can serve as a damage-associated molecular pattern (DAMP;
Kang et al., 2014; Sims et al., 2010; Malarkey & Churchill,
2012). Therefore, understanding the mechanism by which the
oxidized and reduced forms of HMGB1 lead to the observed
decreased DNA-binding affinity is of particular biological
interest. The solution structure of oxidized box A in an
unbound state (Wang et al., 2013) differs considerably from
the box A–DNA structure (Fig. 4), with r.m.s.d. values of
3.46 and 2.73 A˚ overall and for -helices only, respectively
(Supplementary Table S2). In the oxidized form, helix II of
box A is bent towards helix III and the phenyl ring of Phe37 is
now further from the position needed to intercalate the DNA
(Figs. 4b and 4c). Additionally, the loop between helices I and
II is nearer helix I in the oxidized box A, and helices I and II
are closer to each other owing to the disulfide bridge between
Cys22 and Cys44. This comparison provides an explanation of
how oxidation of box A can result in decreased DNA-binding
affinity.
4. Discussion
Previous structural studies have indicated that the box A
domain binds to noncanonical DNA, for example four-way
junctions (Webb & Thomas, 1999) and cisplatin-modified
DNA (Ohndorf et al., 1999). In contrast, our work not only
demonstrates the ability of the HMGB1 box A domain to bind
linear unmodified DNA, but also reveals a new mode of DNA
recognition for HMG-box proteins, in which two domains act
together to underwind and kink DNA. Thus, the HMGB1 box
A–DNA structure reported here shows two important
features: the changes that the box A domain causes in linear
unmodified DNA and their ability to act in a concerted way.
HMGB1 is ubiquitously expressed at a very high level in the
cell (an average of 106 molecules; Catez et al., 2004) and it is
known that it is overexpressed in most tumors, including
leukemia, hepatocellular carcinoma and gastric and colorectal
adenocarcinomas (reviewed by Mu¨ller et al., 2004). It is thus
tempting to speculate that such situations might favor the
formation of complexes in which two protein molecules are
involved in DNA binding.
4.1. The HMGB1 box A domain
distorts linear DNA
The interaction of two box A
domains creates the largest
distortion of the roll and twist
angles in a base-pair step
observed to date for an HMG
box (Stott et al., 2006; Ohndorf
et al., 1999; Murphy et al., 1999;
Allain et al., 1999; Ngo et al.,
2011, 2014; Rubio-Cosials et al.,
2011). Interestingly, the HMG
boxes from HMGD and NHP6A,
as well as sequence-specific
HMG-box domains, are structu-
rally more similar to box B
than to box A (Stott et al.,
2006; Ohndorf et al., 1999;
Murphy et al., 1999; Allain et al.,
1999). Thus, the structural
differences of box A and box B
might relate to their ability to
distort DNA differently, for
example one kinking and the
other smoothly bending the
DNA.
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Figure 4
Comparison of box A structures and Phe conformations. Superimposition of box A from this structure
(cyan) with (a) box A from cisplatin-modified DNA (PDB entry 1ckt; gray; Ohndorf et al., 1999), (b) box A
from the solution structure of the oxidized form (PDB entry 2rtu; gray; Wang et al., 2013) and (c) the C22S
mutant box A free reduced form (PDB entry 1aab; gray; Hardman et al., 1995).
Despite the observations that the HMG boxes of HMGB1
do not show any sequence specificity (Teo, Grasser & Thomas,
1995), in the box A–DNA structure we find that the inter-
calation of Phe37 occurs in the pyrimidine–purine base step
CG. The pyrimidine–purine steps are the most deformable
sequence in DNA and show a high flexibility in many protein–
DNA complexes (Olson et al., 1998). It was also found to be a
favored base step in binding-site selection studies of HMGD
(Churchill et al., 1995). Remarkably, a mutant of HMGD,
HMGD-M13A, which loses the ability to intercalate DNA at
the 1 site, has the 2 intercalating residue also located
between a pyrimidine–purine step (Churchill et al., 2010).
These similarities in intercalation-site sequence support the
model that structure-specific binding of HMGB proteins is
based on the deformability of their binding substrates
(Murphy & Churchill, 2000).
4.2. Oligomerization of HMG proteins in DNA binding
A distinctive feature of our structure is the presence of two
HMGB domains acting together on the same DNA-binding
site. This is the first time that such a joint action has been
reported.
Oligomerization of individual HMGB1 boxes and a HMGB
didomain has been observed when bound to supercoiled
circular and linear DNA, as reported by Teo, Grasser &
Thomas (1995) in cross-linking assays. Additionally, HMGB1
exhibits cooperative binding to DNA mini-circles (Webb et al.,
2001). Finally, in electron-microscopy experiments, oligomeric
protein ‘beads’ were observed at the bases of the loops and at
the crossovers created by the didomain on circular and linear
DNA, which could lead to DNA compaction (Sˇtros, Sˇtokrova´
et al., 1994; Sˇtros, Reich et al., 1994).
Other observations of HMG-box associations include
TFAM and HMGD. TFAM binds to the mitochondrial
genomic DNA, compacting it into the mitochondrial nucleoid
(Kaufman et al., 2007). Interestingly, recent crystallographic
studies of the structure of TFAM bound to DNA (Ngo et al.,
2011, 2014; Rubio-Cosials et al., 2011) showed a crystal-
packing contact mediated by the interaction of two HMG box
A helices III (Ngo et al., 2014). Substitution of amino-acid
residues designed to disrupt this interaction led to a mutant of
TFAM that had a decreased ability to compact DNA but that
retained the ability to bind DNA, bend DNA and activate
transcription (Ngo et al., 2014). For the single HMG-box
protein HMGD, cooperative binding to linear DNA giving rise
to multimeric complexes has been
observed (Churchill et al., 1999). The
crystal structures of both the HMG box
of HMGD (Murphy et al., 1999) and an
HMGD intercalation mutant bound to
DNA (Churchill et al., 2010) showed
interactions of helix III either from
adjacent HMG boxes within the asym-
metric unit or from HMG boxes at the
sites of crystal-packing contacts. More-
over, HMGD exhibited head-to-head
and head-to-tail binding orientations.
Although it is not known which of these
modes of oligomerization HMGD uses
in vivo, the observation of similar types
of HMG box–HMG box interactions in
quite different HMGB proteins suggests
that there are multiple ways in which
HMG boxes can bind, bend and
compact DNA.
In our structure of HMGB1 box A,
the two boxes could either come toge-
ther to bind DNA or the binding of one
box A could facilitate the binding of the
second box. In Fig. 5 we show a model
of how DNA could be bent when the
binding of two whole HMGB1 proteins
(with box A and box B) is considered.
Besides the kinking of DNA imposed by
the binding of the two boxes A (Fig. 5a),
the binding of the box B of both
molecules could originate a loop (Fig.
5b) or other conformations (Fig. 5c) in
DNA.
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Figure 5
Schematic model of the organization of two HMGB1 molecules with each box A bound to the same
DNA-binding site, as in our structure. The binding of box A (in purple) of both proteins through the
Phe37 pair kinks the DNA by about 85 (a). The binding of each box B domain (in green) can
originate the formation of a loop (b) or other DNA conformation (c). For simplicity, the acidic tails
have not been drawn.
4.3. Chromatin modulation by HMGB1 and H1
The binding of the box A domain to B-DNA is of utmost
biological importance since HMGB1 is a key architectural
protein in chromatin and subtle changes such as oxidation
have dramatic functional consequences. It has been estab-
lished that H1 and HMGB1 can contribute to modulation of
the chromatin structure and both present similar binding sites
within linker DNA (Sˇtros, 2010). It has been repeatedly
proposed that HMGB1 could displace linker H1 histones from
DNA or chromatin (reviewed by Thomas & Stott, 2012; Ner et
al., 2001; Jackson et al., 1979). Recent studies demonstrate that
oxidized HMGB1 has a limited capacity for H1 displacement
and the redox state of HMGB1 modulates the ability to bind
and bend DNA (Polanska et al., 2014). Our comparison of the
structures of oxidized box A (with the disulfide bridge Cys22–
Cys44) with box A bound to DNA in our structure provides an
explanation for the decrease of affinity owing to the different
availability of Phe37 to intercalate DNA.
In conclusion, we show how box A is able to bind linear
unmodified DNA, unwind it and create a kink of 85 by means
of two box A domains acting together in a symmetric manner.
Our results open the possibility that the simultaneous binding
of these two domains could be indicative of a concerted action
of two HMGB1 molecules to bend DNA in vivo. Further
research is required to ascertain whether this concerted
binding is cooperative and whether it can also be extended to
other HMG-box-containing proteins.
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